[Asia Economy Reporter Hyunseok Yoo] EID and Isu Abxis are showing strong performance. It appears that news of Brazil and Slovakia starting approval and vaccination of the COVID-19 vaccine Sputnik V has had an impact.
As of 10:26 AM on the 7th, Isu Abxis was trading at 16,450 KRW, up 1.23% (200 KRW) compared to the previous trading day. At the same time, EID also rose by 6.30%.
According to the Russian sovereign wealth fund RDIF, Brazil has given final approval for vaccination with Russia's Sputnik V. Slovakia, which approved Sputnik V as the second EU member country after Hungary, has started vaccine vaccinations.
Isu Abxis is expected to begin initial production of Sputnik V this month or next month after receiving technology transfer of the Russian vaccine. EID, along with its affiliate Etron, made an investment of about 20 billion KRW last December in Korea Koros, a contract manufacturing company for Sputnik V.
The Russian sovereign wealth fund RDIF announced on its official website that Brazil became the 67th country to approve the Sputnik V vaccine, bringing the total vaccination target population of countries approving Sputnik V to approximately 3.4 billion people, making it the second largest in the world by number of approving countries.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
